|
Gujarat leads in pharma exports with highest number of 280 WHO-GMP certified manufacturing units followed by Maharashtra
|
|
Shardul Nautiyal, Mumbai
September 30 , 2017
|
|
|
Gujarat has achieved the distinction of having the highest number of 280
WHO – GMP certified manufacturing units in the country followed by
Maharashtra with 222 units, Himanchal Pradesh at 134, Telangana at 131
and Uttarakhand at 97.
West Bengal has the least number of 4
WHO-GMP certified manufacturing units with Sikkim being the only state
in the North- Eastern region of the country having 16 WHO – GMP
certified manufacturing units.
Accounting for nearly 40 per cent
of India’s pharma production and 28 per cent of pharma exports, Gujarat
has registered a growth of 445 per cent in pharma exports in the past
one decade. Exports worth 3,060 million US Dollars has been achieved in
2016 from Gujarat in comparison to exports worth 562 million US Dollars
in 2006.
Other Union Territories and states like Arunachal
Pradesh, Andaman & Nicobar, Assam, Bihar, Chandigarh, Chhattisgarh,
Jharkhand, Lakshadweep, Manipur, Meghalaya, Mizoram, Nagaland, Tripura
and Odisha have no WHO-GMP certified manufacturing units.
The
country today has a total of 1314 WHO -GMP certified manufacturing
units. Besides this, Gujarat has 24 TGA certified, 15 EU certified and
16 PICS certified manufacturing units. It boasts of 158 formulation
units and 97 bulk drug units. It has 40 per cent of CROs and 40 per cent
of CRAMS companies.
Over 3300 manufacturing units are located
across the state in four large clusters with 5 Special Economic Zones in
an area of over 1500 hectares, as per official data.
The growth
in pharma exports would also get a boost with setting up of a dedicated
medical device testing lab for the first time in the country at
Vadodara in Gujarat. A final proposal on the same has been sent to the
Union health ministry for its implementation.
India today lacks
in registering and thereby reporting adverse events due to faulty
medical devices at the point of care. Gujarat is also coming up with a
manufacturing park for medical devices at Sanand. Medical devices
manufacturing requires certain high investment facilities which are too
capital intensive for individual manufacturers to invest upon. A park
with in-house high investment scientific facilities would help
manufacturers reduce the cost of manufacturing by more than 40 per cent
to 50 per cent.
Currently, due to lack of such centrally located
common facilities, manufacturers do not undertake production of
technologies and therefore send their products abroad for process
up-gradation and value addition.
|
|
|
|
|
|
|
|
TOPICS
|
That foods might provide therapeutic benefits is clearly not a new concept. ...
|
|
|
|
|